Key facts
- It has raised $8.0M; the latest was Later Stage VC ($8.0M) in Sep 2025.
- Notable investors include L Catterton, Unilever Ventures, Starshot Ventures, HEPCO Capital Management, Red Flyer Investments — 15 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 15 names
- ·Watchlist + deal alerts for Alice Mushrooms
- ·The full record, as it builds
Funding rounds
No funding rounds for Alice Mushrooms are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Alice Mushrooms
Operator of the mushroom chocolate brand intended to offer boosts to cognitive functioning. The company's products provide instant sensation without chemicals or capsules, without the next-morning grogginess of traditional sleep aids, enabling consumers to benefit from antioxidant properties, cardiovascular protection, antibacterial properties, and anti-inflammatory properties.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Los Angeles, CA, United States
- Founded
- 2020
- Employees
- 10
- Website
- alicemushrooms.com/
- Ownership
- Privately Held (backing)
Alice Mushrooms doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Alice Mushrooms shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Alice Mushrooms in its N-PORT filings yet. We sweep new filings monthly.